Mural Oncology plc (MURA) — Net Asset Quality Index
Mural Oncology plc (MURA) has a Net Asset Quality Index of 83.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $65.76 Million minus total liabilities of $10.57 Million yields net assets of $55.19 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read MURA total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mural Oncology plc Net Asset Quality Index Over Time (2021–2024)
This chart shows how Mural Oncology plc's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 83.9%, representing net assets of $55.19 Million against total assets of $65.76 Million USD. For live market cap and overall valuation, see market cap of Mural Oncology plc.
Annual Net Asset Quality Index for Mural Oncology plc (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for Mural Oncology plc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Mural Oncology plc (MURA) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 82.9% | $140.50 Million | $169.39 Million | $28.89 Million | ▼ -4.5 pp |
| 2023 | 87.4% | $263.82 Million | $301.75 Million | $37.93 Million | ▲ +151.6 pp |
| 2022 | -64.2% | $-21.66 Million | $33.75 Million | $55.41 Million | ▼ -13.2 pp |
| 2021 | -50.9% | $-17.88 Million | $35.11 Million | $52.99 Million | — |